Universal Anti-Viral Vaccine for Healthy Elderly Adults
Status:
Recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
This protocol tests the safety and efficacy of a novel universal vaccine concept called
"allo-priming" which is designed to protect elderly adults from progression of any type of
viral infection, including possible protection against progression of the current outbreak of
COVID-19 infection, and any future variants, strains, mutations of the causative SARS-CoV-2
virus as well as protection from any future currently unknown newly emergent novel viruses.